Dr Ogechi Paschal-Ejiogu has been appointed to the board of directors of the Nigeria Sovereign Investment Authority (NSIA) by President Muhammadu Buhari, effective January 6, 2022.
Paschal-Ejiogu replaces Mr Ike Chioke, the former appointee for Nigeria’s South-East region, who requested to be relieved of board duty at the NSIA following his appointment in 2021, as his firm was appointed to support the government in another role.
In announcing her appointment, the NSIA stated that Dr Paschal-Ejiogu brings nearly two decades of cognate experience spanning the social services and healthcare industries to the NSIA Board of Directors.
She is a doctoral-level academic with extensive knowledge of complex economic concepts and the ability to apply theories and ideas to real-world situations. She also has a strong understanding of business finance, econometric modelling, data analysis, planning, and interpretation, and has made significant contributions to the social services and healthcare industries in both Nigeria and the United States of America over the last two decades.
She earned a Doctorate in Economics with honours from Howard University (USA) in Washington, DC, with a focus on Public Policy and Development. Dr Paschal-Ejiogu previously earned a Masters in Development Economics and Policy from the University of Reading in the United Kingdom, as well as a BSc. in Economics from Imo State University.
Mr Farouk Gumel, chairman of the NSIA Board of Directors, stated, “We are pleased to welcome Dr Ogechi Paschal-Ejiogu to the Board.” We thank His Excellency, President Muhammadu Buhari, for prioritizing NSIA Board appointments, as well as for selecting Dr Paschal-Ejiogu, who brings invaluable international experience to the Board”.
Mr Uche Orji, MD & CEO NSIA, stated in his comment, “Dr Paschal-academic Ejiogu’s pedigree and deep experience in the social services and healthcare industries make her a unique addition to the Board. Her extensive experience will help the Authority achieve its long-term strategic objectives. We are delighted with the appointment and look forward to collaborating with Dr Ogechi Paschal-Ejiogu and the Board”.